Advances in Cancer Immunotherapy: A Focus on Women’s Malignancies
Join SITC and a panel of experts for an afternoon of in-depth education on all aspects of clinical implementation of immunotherapy for women’s malignancies.
Related Articles
Illuminating Compassion in Cancer Care
The journey that led to the creation of the Extraordinary Healer Award for Oncology Nursing began with a simple, yet profound, observation.
Cardiometabolic Considerations for Childhood Cancer Survivors Explained
The American Heart Association has released a statement detailing cardiometabolic considerations for survivors of childhood cancer.
Early Intervention and Screening Prevents Lymphedema After Cancer
Dr. Sheri Yolanda Prentiss discusses lymphedema as a result of cancer treatment and shares resources that exist for patients coping with this condition.
Reassessing Immunotherapy Use in Advanced Renal Cell Carcinoma
There is currently no strong evidence that additional immune therapy benefits patients with renal cell carcinoma who were treated in the advanced setting.
Recognizing Symptoms During Head and Neck Cancer Awareness Month
Dr. Zafar Sayed discuss the importance of recognizing Head and Neck Cancer Awareness Month and highlights early symptoms of the disease to be aware of.
AI Tool May Better Predict Transplant Risk in Myelofibrosis
An AI model may help identify patients with myelofibrosis at high risk of early death after transplant, according to an expert.
Daffodils and Determination from a Patient with Chronic Lymphocytic Leukemia
Each spring, I find strength and hope in the daffodils I grow, helping me face chronic lymphocytic leukemia with renewed determination.
First Patient Dosed in a Phase 1/2 Trial for Small Cell Lung Cancer
The first patient with small cell lung cancer has been dosed in a phase 1/2 trial investigating first-line iadademstat plus immune checkpoint inhibitors.
First Patient with Colon Cancer Dosed in a Phase 2 Study of TCMCB07
The first patient has received TCMCB07 in a phase 2 trial to prevent weight loss in patients with metastatic colorectal cancer undergoing chemotherapy.
BELLA Clinical Trial Initiated in Platinum-Resistant Ovarian Cancer
The BELLA phase 2 clinical trial of relacorilant plus nab-paclitaxel and Avastin among patients with platinum-resistant ovarian cancer has been launched.